A central neuropathic pain model by DSP-4 induced lesion of noradrenergic neurons: Preliminary report

Neuroscience Letters

Volumn 481, Issue 2, 2010, Pages 102-104

  Kudo, Takashi ^a   Kushikata, Tetsuya ^a   Kudo, Mihoko ^a   Kudo, Tsuyoshi ^a   Hirota, Kazuyoshi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Central pain; DSP 4; Locus coeruleus; Norepinephrine

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; NORADRENALIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; HIPPOCAMPUS; HOT PLATE TEST; LOCUS CERULEUS; NEUROPATHIC PAIN; NONHUMAN; NORADRENALIN UPTAKE; NORADRENERGIC NERVE; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; TAIL FLICK TEST;

EID: 77955269042     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.06.061     Document Type: Article

References (13)

1. Archer T., Ögren S.O., Johansson G., Ross S.B. DSP4-induced two-way active avoidance impairment in rats: involvement of central and not peripheral noradrenaline depletion. Psychopharmacology 1982, 76:303-309.
2. Dahlstroem A., Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. Suppl. 1964, 232:1-55.
3. Fornai F., Saviozzi M., Piaggi S., Gesi M., Corsini G.U., Malvaldi G., Casini A.F. Localization of a glutathione-dependent dehydroascorbate reductase within the central nervous system of the rat. Neuroscience 1999, 94:937-948.
4. Fritschy J.M., Grzanna R. Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system?. Prog. Brain Res. 1991, 88:257-268.
5. Fukui M., Takishita A., Zhang N., Nakagawa T., Minami M., Satoh M. Involvement of locus coeruleus noradrenergic neurons in supraspinal antinociception by α, β-methylene-ATP in rats. J. Pharmacol. Sci. 2004, 94:153-160.
6. Jones S.L. Descending noradrenergic influences on pain. Prog. Brain Res. 1991, 88:381-394.
7. Ossipov M.H., Kovelowski C.J., Nichols M.L., Hruby V.J., Porreca F. Characterization of spuraspinal antinociceptive actions of opioid delta agonists in the rat. Pain 1995, 62:287-293.
8. Pucilowski O., Trzaskowska E., Kostowski W., Valzelli L. Norepinephrine-mediated suppression of apomorphine-induced aggression and locomotor activity in the rat amygdala. Pharmacol. Biochem. Behav. 1987, 26:217-222.
9. West W.L., Yeomans D.C., Proudfit H.K. The function of noradrenergic neurons in mediating antinociception induced by electrical stimulation of the locus coeruleus in two different sources of Sprague-Dawley rats. Brain Res. 1993, 626:127-135.
10. Woolf C.J., Mannion R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999, 353:1959-1964.
11. Yang S.W., Zhang Z.H., Wang R., Xie Y.F., Quiao J.T., Dafny N. Norepinephrine and serotonin-induced antinociception are blocked by naloxone with different dosages. Brain Res. Bull. 1994, 35:113-117.
12. Zhang C., Davies F., Guo T.Z., Maze M. The analgesic action of nitrous oxide is dependent on the release of norepinephrine in the dorsal horn of the spinal cord. Anesthesiology 1999, 91:1401-1407.
13. Zimmermann M. Pathobiology of neuropathic pain. Eur. J. Pharmacol. 2001, 429:23-37.